Anaptysbio, Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ANAB

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

30,508

Value ($000)

1,479

Weight

0.0%

2020 Q1 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,479	0.0%	30,508	12/31/2025
2025 Q3	11/14/2025	1,019	0.0%	33,271	9/30/2025
2025 Q2	8/14/2025	1,106	0.0%	49,805	6/30/2025
2025 Q1	5/19/2025	649	0.0%	34,913	3/31/2025
2024 Q4	2/14/2025	390	0.0%	29,479	12/31/2024
2024 Q3	11/14/2024	1,102	0.0%	32,884	9/30/2024
2024 Q2	8/14/2024	743	0.0%	29,661	6/30/2024
2024 Q1	5/15/2024	381	0.0%	16,921	3/31/2024
2023 Q4	2/14/2024	362	0.0%	16,921	12/31/2023
2023 Q3	11/13/2023	304	0.0%	16,921	9/30/2023
2023 Q2	8/11/2023	368	0.0%	16,921	6/30/2023
2023 Q1	5/15/2023	368	0.0%	16,921	3/31/2023
2022 Q3	11/14/2022	587	0.0%	23,007	9/30/2022
2022 Q2	8/12/2022	297	0.0%	14,646	6/30/2022
2022 Q1	5/16/2022	569	0.0%	23,007	3/31/2022
2021 Q4	2/14/2022	799	0.0%	23,007	12/31/2021
2021 Q3	11/15/2021	659	0.0%	24,314	9/30/2021
2021 Q2	8/16/2021	630	0.0%	24,314	6/30/2021
2021 Q1	5/14/2021	316	0.0%	14,646	3/31/2021
2020 Q4	3/1/2021	363	0.0%	16,873	12/31/2020
2020 Q3	11/13/2020	249	0.0%	16,873	9/30/2020
2020 Q2	8/14/2020	377	0.0%	16,873	6/30/2020
2020 Q1	5/15/2020	203	0.0%	14,349	3/31/2020